These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


153 related items for PubMed ID: 1848519

  • 1. Hypothalamic binding sites for pituitary adenylate cyclase activating polypeptide: characterization and molecular identification.
    Gottschall PE, Tatsuno I, Arimura A.
    FASEB J; 1991 Feb; 5(2):194-9. PubMed ID: 1848519
    [Abstract] [Full Text] [Related]

  • 2. Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide.
    Gottschall PE, Tatsuno I, Miyata A, Arimura A.
    Endocrinology; 1990 Jul; 127(1):272-7. PubMed ID: 2361473
    [Abstract] [Full Text] [Related]

  • 3. Investigation and characterization of receptors for pituitary adenylate cyclase-activating polypeptide in human brain by radioligand binding and chemical cross-linking.
    Suda K, Smith DM, Ghatei MA, Murphy JK, Bloom SR.
    J Clin Endocrinol Metab; 1991 May; 72(5):958-64. PubMed ID: 1673686
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of mitogen-stimulated proliferation of murine splenocytes by a novel neuropeptide, pituitary adenylate cyclase activating polypeptide: a comparative study with vasoactive intestinal peptide.
    Tatsuno I, Gottschall PE, Arimura A.
    Endocrinology; 1991 Feb; 128(2):728-34. PubMed ID: 1989859
    [Abstract] [Full Text] [Related]

  • 5. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
    Zawilska JB, Dejda A, Niewiadomski P, Gozes I, Nowak JZ.
    J Mol Neurosci; 2005 Feb; 25(3):215-24. PubMed ID: 15800375
    [Abstract] [Full Text] [Related]

  • 6. Functional characterization and mRNA expression of pituitary adenylate cyclase activating polypeptide (PACAP) type I receptors in rat peritoneal macrophages.
    Pozo D, Delgado M, Martinez C, Gomariz RP, Guerrero JM, Calvo JR.
    Biochim Biophys Acta; 1997 Dec 12; 1359(3):250-62. PubMed ID: 9434131
    [Abstract] [Full Text] [Related]

  • 7. Two high affinity binding sites for pituitary adenylate cyclase-activating polypeptide have different tissue distributions.
    Shivers BD, Görcs TJ, Gottschall PE, Arimura A.
    Endocrinology; 1991 Jun 12; 128(6):3055-65. PubMed ID: 2036976
    [Abstract] [Full Text] [Related]

  • 8. Specific binding sites for pituitary adenylate cyclase activating polypeptide (PACAP) in rat cultured astrocytes: molecular identification and interaction with vasoactive intestinal peptide (VIP).
    Tatsuno I, Gottschall PE, Arimura A.
    Peptides; 1991 Jun 12; 12(3):617-21. PubMed ID: 1923939
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Characterization of a guanosine-nucleotide-binding-protein-coupled receptor for pituitary adenylate-cyclase-activating polypeptide on plasma membranes from rat brain.
    Schäfer H, Schwarzhoff R, Creutzfeldt W, Schmidt WE.
    Eur J Biochem; 1991 Dec 18; 202(3):951-8. PubMed ID: 1662620
    [Abstract] [Full Text] [Related]

  • 11. Demonstration of specific binding sites for pituitary adenylate cyclase activating polypeptide (PACAP) in rat astrocytes.
    Tatsuno I, Gottschall PE, Köves K, Arimura A.
    Biochem Biophys Res Commun; 1990 May 16; 168(3):1027-33. PubMed ID: 2346475
    [Abstract] [Full Text] [Related]

  • 12. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB, Niewiadomski P, Nowak JZ.
    Gen Comp Endocrinol; 2004 Jun 16; 137(2):187-95. PubMed ID: 15158130
    [Abstract] [Full Text] [Related]

  • 13. Molecular identification of receptor for pituitary adenylate cyclase activating polypeptide.
    Ohtaki T, Watanabe T, Ishibashi Y, Kitada C, Tsuda M, Gottschall PE, Arimura A, Fujino M.
    Biochem Biophys Res Commun; 1990 Sep 14; 171(2):838-44. PubMed ID: 2169736
    [Abstract] [Full Text] [Related]

  • 14. Investigation of the interaction of VIP binding sites with VIP and PACAP in human brain.
    Suda K, Smith DM, Ghatei MA, Bloom SR.
    Neurosci Lett; 1992 Mar 16; 137(1):19-23. PubMed ID: 1320752
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM, Carmena MJ, Carrero I, Cavallaro S, Roman F, Hueso C, Travali S, Lopez-Fraile N, Guijarro LG, Prieto JC.
    Endocrinology; 1996 Jul 16; 137(7):2815-22. PubMed ID: 8770902
    [Abstract] [Full Text] [Related]

  • 17. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors in chick cerebral cortex.
    Zawilska JB, Niewiadomski P, Nowak JZ.
    J Mol Neurosci; 2003 Apr 16; 20(2):153-62. PubMed ID: 12794309
    [Abstract] [Full Text] [Related]

  • 18. Prohormone convertases 1 and 2 process ProPACAP and generate matured, bioactive PACAP38 and PACAP27 in transfected rat pituitary GH4C1 cells.
    Li M, Shuto Y, Somogyvári-Vigh A, Arimura A.
    Neuroendocrinology; 1999 Mar 16; 69(3):217-26. PubMed ID: 10087454
    [Abstract] [Full Text] [Related]

  • 19. Specific antibody recognition of rat pituitary adenylate cyclase activating polypeptide receptors.
    Li M, Shioda S, Somogyvári-Vigh A, Onda H, Arimura A.
    Endocrine; 1997 Oct 16; 7(2):183-90. PubMed ID: 9549044
    [Abstract] [Full Text] [Related]

  • 20. Localization and characterization of PACAP receptors in the rat cerebellum during development: evidence for a stimulatory effect of PACAP on immature cerebellar granule cells.
    Basille M, Gonzalez BJ, Leroux P, Jeandel L, Fournier A, Vaudry H.
    Neuroscience; 1993 Nov 16; 57(2):329-38. PubMed ID: 8115042
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.